FDMT
4D Molecular Therapeutics Inc.
$10.82
-$0.41(-3.61%)
64
Overall
60
Value
83
Tech
50
Quality
Market Cap
$559.03M
Volume
398.94K
52W Range
$2.24 - $12.34
Target Price
$31.25
EPS Estimates Overview
| Current Quarter | $-1.02 | Next Quarter | $-0.98 |
| Current Year | $-3.74 | Next Year | $-3.88 |
| QoQ Growth | +3.9% | YoY Growth | -3.7% |
| 3Y EPS CAGR | -5.1% | Target Price | $31.25 |
| Consensus | Buy | Upside | +189.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FDMT | $10.82 | -3.6% | 398.94K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get 4D Molecular Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW